ASTX-029 is an orally bioavailable inhibitor of the extracellular signal-regulated kinases (ERK) 1 and 2, with potential antineoplastic activity. ASTX-029 inhibits ERK-dependent tumor cell proliferation and survival.
CAS Number:
[2095719-92-7]
* VAT and and shipping costs not included. Errors and price changes excepted